肝细胞癌
细胞外小泡
等离子体子
限制
纳米技术
液体活检
癌症研究
化学
癌症
肝癌
检出限
癌症检测
细胞外
材料科学
过程(计算)
纳米颗粒
计算机科学
光电子学
炸薯条
生物标志物
合理设计
生物传感器
临床实习
癌细胞
活检
癌症生物标志物
纳米医学
诊断生物标志物
癌
生物医学工程
表面等离子共振
作者
Jiaheng Zhu,C.C. Wang,Tianhao Huang,Longhui Zeng,Qiang Niu,Xinyue Huang,Hanyang Chen,Mengqi Jiang,Baichang Deng,Yiming Yan,Xiaohui Liu,Junjie Chen,Yinong Xie,Jiaqing Shen,Wei Chen,Yuan Gao,Kaibin Chen,Xiangyujie Lin,Lijun Zeng,Bo Li
出处
期刊:ACS Nano
[American Chemical Society]
日期:2025-12-04
卷期号:19 (49): 41557-41570
被引量:2
标识
DOI:10.1021/acsnano.5c11740
摘要
Hepatocellular carcinoma (HCC) is a leading cause of global cancer-related mortality, with delayed diagnosis adversely affecting patient outcomes. Liquid biopsy techniques using small extracellular vesicles (EVs) offer potential for cancer detection, though current methods are often time-consuming and require complex equipment, limiting clinical utility. Here, we report a metasurface-enhanced EV detection chip (metaEVchip) platform for the dynamic monitoring of HCC-specific EVs, enabling rapid detection and purification. This system provides results within 5 min. The platform integrates a plasmonic metasurface with a Kolmogorov-Arnold network (KAN) to facilitate real-time EV capture, enhancing detection speed while achieving an area under the curve (AUC) of 0.914 for HCC screening. By optimizing the purification process and incorporating complementary detection of alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKAII), the AUC for HCC screening reaches 0.961 in an external validation set. These results effectively differentiate HCC from benign liver diseases (BLD) and early-stage HCC from cirrhosis, addressing limitations of conventional EV detection and demonstrating the potential for rapid cancer screening.
科研通智能强力驱动
Strongly Powered by AbleSci AI